These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9604912)

  • 1. Guidelines for trials of gene therapy and somatic gene therapy in cardiovascular disease.
    Hoeg JM
    Am J Cardiol; 1998 Apr; 81(8A):60F-63F. PubMed ID: 9604912
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapist, heal thyself.
    Rosenberg LE; Schechter AN
    Science; 2000 Mar; 287(5459):1751. PubMed ID: 10755924
    [No Abstract]   [Full Text] [Related]  

  • 3. LncRNAs Coming of Age.
    Grote P; Boon RA
    Circ Res; 2018 Aug; 123(5):535-537. PubMed ID: 30355139
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidance for human somatic cell therapy and gene therapy.
    U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research.
    Hum Gene Ther; 2001 Feb; 12(3):303-14. PubMed ID: 11177566
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulating the gene-therapy revolution.
    Bender E
    Nature; 2018 Dec; 564(7735):S20-S22. PubMed ID: 30542185
    [No Abstract]   [Full Text] [Related]  

  • 6. Recommendations proposed for adenovirus gene therapy trials in the UK.
    Nevin NC; Spink J
    Mol Med Today; 2000 Dec; 6(12):461. PubMed ID: 11187936
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gene therapy: many more questions than answers].
    Cavazzana M
    Med Sci (Paris); 2017 May; 33(5):461-462. PubMed ID: 28612713
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee.
    Hum Gene Ther; 2002 Jan; 13(1):3-13. PubMed ID: 11779411
    [No Abstract]   [Full Text] [Related]  

  • 9. New ISSCR guidelines underscore major principles for responsible translational stem cell research.
    Hyun I; Lindvall O; Ahrlund-Richter L; Cattaneo E; Cavazzana-Calvo M; Cossu G; De Luca M; Fox IJ; Gerstle C; Goldstein RA; Hermerén G; High KA; Kim HO; Lee HP; Levy-Lahad E; Li L; Lo B; Marshak DR; McNab A; Munsie M; Nakauchi H; Rao M; Rooke HM; Valles CS; Srivastava A; Sugarman J; Taylor PL; Veiga A; Wong AL; Zoloth L; Daley GQ
    Cell Stem Cell; 2008 Dec; 3(6):607-9. PubMed ID: 19041777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy on the RAC.
    Steele FR
    Mol Ther; 2000 Jan; 1(1):1-2. PubMed ID: 10933902
    [No Abstract]   [Full Text] [Related]  

  • 11. A straightforward guide to the basic science behind cardiovascular cell-based therapies.
    Goumans MJ; Maring JA; Smits AM
    Heart; 2014 Aug; 100(15):1153-7. PubMed ID: 24993501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Product release assays.
    Gee AP
    Cytotherapy; 1999; 1(6):485-91. PubMed ID: 20426549
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene therapy in cardiovascular disease: state of the art.
    White DC; Milano CA
    Ann Surg; 2003 Dec; 238(6 Suppl):S90-7; discussion S98-9. PubMed ID: 14703749
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell and gene therapy manufacturing capabilities in Australia and New Zealand.
    O'Sullivan GM; Velickovic ZM; Keir MW; Macpherson JL; Rasko JEJ
    Cytotherapy; 2019 Dec; 21(12):1258-1273. PubMed ID: 31806531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harm, ethics committees and the gene therapy death.
    Savulescu J
    J Med Ethics; 2001 Jun; 27(3):148-50. PubMed ID: 11417019
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience of gene therapy in the United Kingdom.
    Nevin NC
    Ann N Y Acad Sci; 1998 Dec; 862():184-7. PubMed ID: 9928223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for cardiovascular diseases.
    Nabel EG
    J Nucl Cardiol; 1999; 6(1 Pt 1):69-75. PubMed ID: 10070842
    [No Abstract]   [Full Text] [Related]  

  • 18. Implementation of cardovascular cell therapy network trials: challenges, innovation and lessons learned from experience in the CCTRN.
    Park KE; Moyé LA; Henry TD; Perin EC; Sayre SL; Bettencourt J; Vojvodic RW; Olson RE; Pepine CJ;
    Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1495-502. PubMed ID: 24147517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidance for human somatic cell therapy and gene therapy. March 1998. Center for Biologics Evaluation and Research, Food and Drug Administration.
    Hum Gene Ther; 1998 Jul; 9(10):1513-24. PubMed ID: 9681422
    [No Abstract]   [Full Text] [Related]  

  • 20. Current gene therapy trials for vascular diseases.
    Halonen PJ; Nurro J; Kuivanen A; Ylä-Herttuala S
    Expert Opin Biol Ther; 2014 Mar; 14(3):327-36. PubMed ID: 24387602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.